SNOA
SNOA
NASDAQ · Pharmaceuticals

Sonoma Pharmaceuticals Inc

$1.17
-0.01 (-0.85%)
As of May 9, 2:26 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,005.1% upside
Low Target $7.21
Average Target $12.93
High Target $14.12
Current Price $1.17
Current
$1.17
Target
$12.93
$7.21 $12.93 avg $14.12
Scenario Analysis
Bear Case
$7.21
516.2%
Low target
Base Case
$12.93
+1,005.1%
Avg target
Bull Case
$14.12
+1,106.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$6.92
-83.1% from high
52-Week Low
$0.85
+37.6% from low
Target vs 52W High
$12.93
+86.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%